Back
BioCryst Pharmaceuticals, Inc. Vs. Credit Acceptance Corp. Industry Stock Comparison
Buy
59
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$9.03
Seasonality Move:
15.89%
Sell
34
CACC
Credit Acceptance Corp.
Last Price:
$416.51
Seasonality Move:
11.08%
Buy
59
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $9.02. The Score for BCRX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
BCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Credit Acceptance Corp. (CACC)
is a Sell
Is Credit Acceptance Corp. a Buy, Sell or Hold?
-
The current Credit Acceptance Corp. [CACC] share price is $416.51. The Score for CACC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CACC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals, Inc.'s stock price today?
-
The BioCryst Pharmaceuticals, Inc. share price today is $9.02The current trend is moderately bearish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
CACC Stock Price Chart
What is Credit Acceptance Corp.'s stock price today?
-
The Credit Acceptance Corp. share price today is $416.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CACC is experiencing slight selling pressure.
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 52.42 | Buy |
| Chaikin Money Flow: | -4182320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.57 - 9.55) | Sell |
| Bollinger Bands (100): | (6.71 - 8.57) | Buy |
CACC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -16.86 | Sell |
| Relative Strength Index (14 RSI): | 33.09 | Sell |
| Chaikin Money Flow: | -8047 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (429.4 - 489.82) | Sell |
| Bollinger Bands (100): | (437.27 - 488.91) | Sell |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.42 | Sell |
| 20-day SMA: | 9.16 | Sell |
| 50-day SMA: | 7.98 | Buy |
| 200-day SMA: | 7.88 | Buy |
| 8-day EMA: | 9.34 | Sell |
| 20-day EMA: | 9.09 | Sell |
| 50-day EMA: | 8.4 | Buy |
| 200-day EMA: | 7.91 | Buy |
CACC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 428.43 | Sell |
| 20-day SMA: | 452.62 | Sell |
| 50-day SMA: | 472.14 | Sell |
| 200-day SMA: | 478.86 | Sell |
| 8-day EMA: | 427.64 | Sell |
| 20-day EMA: | 445.67 | Sell |
| 50-day EMA: | 461.7 | Sell |
| 200-day EMA: | 473.9 | Sell |
BioCryst Pharmaceuticals, Inc. Earnings Growth & BCRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.32 per share.
Credit Acceptance Corp. Earnings Growth & CACC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.97 per share, an increase next quarter of $0.81 per share, an increase this year of $8.87 per share, and an increase next year of $6.47 per share.
BioCryst Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Credit Acceptance Corp. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||